Home / HGFR/c-MET / Human HGFR/c-MET Antibody

Human HGFR/c-MET Antibody

Catalog #: AF276
53 Citations Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
AF276
AF276-SP
HGF R/c‑MET in HT‑29 and U937 Human Cell Line.
6 Images
Product Details
Citations (53)
FAQs
Supplemental Products
Reviews
Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human HGFR/c-MET Antibody Summary

Species Reactivity
Human
Specificity
Detects human HGF R/c-MET in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 30% cross-reactivity with recombinant mouse HGF R is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
Mouse myeloma cell line NS0-derived recombinant human HGF R/c-MET
Glu25-Thr932
Accession # P08581
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
0.1 µg/mL
Recombinant Human HGF R/c-MET Fc Chimera (Catalog # 358-MT)
Simple Western
25 µg/mL
HepG2 human hepatocellular carcinoma cell line
Flow Cytometry
2.5 µg/106 cells
MDA‑MB‑231 human breast cancer cell line
Immunohistochemistry
5-15 µg/mL
See below
Blockade of Receptor-ligand Interaction
In a functional ELISA, 0.5-2 µg/mL of this antibody will block 50% of the binding of 5 ng/mL of Recombinant Human HGF (Catalog # 294-HGN) to immobilized Recombinant Human HGF R/c-MET Fc Chimera (Catalog # 358‑MT) coated at 1 µg/mL (100 µL/well). At 10 μg/mL, this antibody will block >90% of the binding.
 
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
 
Immunocytochemistry
5-15 µg/mL
See below
Knockout Validated
HGF R/c‑MET is specifically detected in HeLa human cervical epithelial carcinoma parental cell line but is not detectable in HGF R/c‑MET knockout HeLa cell line.
 

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Immunocytochemistry HGF R/c-MET antibody in HT-29 and U937 Human Cell Line by Immunocytochemistry (ICC). View Larger

HGF R/c‑MET in HT‑29 and U937 Human Cell Line. HGF R/c-MET was detected in immersion fixed HT-29 human colon adenocarcinoma cell line (positive control, left panel) and U937 human histiocytic lymphoma cell line (negative control, right panel) using Goat Anti-Human HGF R/c-MET Antigen Affinity-purified Polyclonal Antibody (Catalog # AF276) at 5 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; NL001) and counterstained with DAPI (blue). Specific staining was localized to plasma membrane. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

Immunohistochemistry HGF R/c-MET antibody in Human Liver by Immunohistochemistry (IHC-P). View Larger

HGF R/c‑MET in Human Liver. HGF R/c-MET was detected in immersion fixed paraffin-embedded sections of human liver using Goat Anti-Human HGF R/c-MET Antigen Affinity-purified Polyclonal Antibody (Catalog # AF276) at 10 µg/mL overnight at 4 °C. Before incubation with the primary antibody tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (CTS013). Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.

Immunohistochemistry HGF R/c-MET antibody in Human Skin by Immunohistochemistry (IHC-P). View Larger

HGF R/c‑MET in Human Skin. HGF R/c-MET was detected in immersion fixed paraffin-embedded sections of human skin using 15 µg/mL Goat Anti-Human HGF R/c-MET Antigen Affinity-purified Polyclonal Antibody (Catalog # AF276) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.

Knockout Validated Western Blot Shows Human HGF R/c-MET Antibody Specificity by Using Knockout Cell Line. View Larger

Western Blot Shows Human HGF R/c‑MET Specificity by Using Knockout Cell Line. Western blot shows lysates of HeLa human cervical epithelial carcinoma parental cell line and HGF R/c-Met knockout HeLa cell line (KO). PVDF membrane was probed with 1 µg/mL of Goat Anti-Human HGF R/c-MET Antigen Affinity-purified Polyclonal Antibody (Catalog # AF276) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (HAF017). Specific bands were detected for HGF R/c-MET at approximately 150-200 kDa (as indicated) in the parental HeLa cell line, but is not detectable in knockout HeLa cell line. GAPDH (AF5718) is shown as a loading control. This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Simple Western View Larger

Detection of Human HGFR/c-MET by Simple WesternTM. Simple Western lane view shows lysates of HepG2 human hepatocellular carcinoma cell line, loaded at 0.2 mg/mL. A specific band was detected for HGFR/c-MET at approximately 151 kDa (as indicated) using 25 µg/mL of Goat Anti-Human HGFR/c-MET Antigen Affinity-purified Polyclonal Antibody (Catalog # AF276). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system.

Flow Cytometry View Larger

Detection of HGFR/c-MET in MDA-MB-231 cells by Flow Cytometry MDA-MB-231 cells were stained with Goat Anti-Human HGFR/c-MET Antigen Affinity-purified Polyclonal Antibody (Catalog # AF276, filled histogram) or isotype control antibody (Catalog # AB-108-C, open histogram) followed by Phycoerythrin-conjugated Anti-Goat IgG Secondary Antibody (Catalog # F0107). View our protocol for Staining Membrane-associated Proteins.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: HGFR/c-MET

HGF R, also known as Met (from N-methyl-N’-nitro-N-nitrosoguanidine induced), is a glycosylated receptor tyrosine kinase that plays a central role in epithelial morphogenesis and cancer development. HGF R is synthesized as a single chain precursor which undergoes cotranslational proteolytic cleavage. This generates a mature HGF R that is a disulfide-linked dimer composed of a 50 kDa extracellular alpha chain and a 145 kDa transmembrane beta chain (1, 2). The extracellular domain (ECD) contains a seven bladed beta -propeller sema domain, a cysteine-rich PSI/MRS, and four Ig-like E-set domains, while the cytoplasmic region includes the tyrosine kinase domain (3, 4). Proteolysis and alternate splicing generate additional forms of human HGF R which either lack of the kinase domain, consist of secreted extracellular domains, or are deficient in proteolytic separation of the alpha and beta chains (5-7). The sema domain, which is formed by both the alpha and beta chains of HGF R, mediates both ligand binding and receptor dimerization (3, 8). Ligand-induced tyrosine phosphorylation in the cytoplasmic region activates the kinase domain and provides docking sites for multiple SH2-containing molecules (9, 10). HGF stimulation induces HGF R downregulation via internalization and proteasome-dependent degradation (11). In the absence of ligand, HGF R forms non-covalent complexes with a variety of membrane proteins including CD44v6, CD151, EGF R, Fas, Integrin alpha 6/ beta 4, Plexins B1, 2, 3, and MSP R/Ron (12-19). Ligation of one complex component triggers activation of the other, followed by cooperative signaling effects (12-19). Formation of some of these heteromeric complexes is a requirement for epithelial cell morphogenesis and tumor cell invasion (12, 16, 17). Paracrine induction of epithelial cell scattering and branching tubulogenesis results from the stimulation of HGF R on undifferentiated epithelium by HGF released from neighboring mesenchymal cells (20). Genetic polymorphisms, chromosomal translocation, overexpression, and additional splicing and proteolytic cleavage of HGF R have been described in a wide range of cancers (1). Within the ECD, human HGF R shares 86-88% aa sequence identity with canine, mouse, and rat HGF R.

References
  1. Birchmeier, C. et al. (2003) Nat. Rev. Mol. Cell Biol. 4:915.
  2. Corso, S. et al. (2005) Trends Mol. Med. 11:284.
  3. Gherardi, E. et al. (2003) Proc. Natl. Acad. Sci. USA 100:12039.
  4. Park, M. et al. (1987) Proc. Natl. Acad. Sci. USA 84:6379.
  5. Crepaldi, T. et al. (1994) J. Biol. Chem. 269:1750.
  6. Prat, M. et al. (1991) Mol. Cell. Biol. 12:5954.
  7. Rodrigues, G.A. et al. (1991) Mol. Cell. Biol. 11:2962.
  8. Kong-Beltran, M. et al. (2004) Cancer Cell 6:75.
  9. Naldini, L. et al. (1991) Mol. Cell. Biol. 11:1793.
  10. Ponzetto, C. et al. (1994) Cell 77:261.
  11. Jeffers, M. et al. (1997) Mol. Cell. Biol. 17:799.
  12. Orian-Rousseau, V. et al. (2002) Genes Dev. 16:3074.
  13. Klosek, S.K. et al. (2005) Biochem. Biophys. Res. Commun. 336:408.
  14. Jo, M. et al. (2000) J. Biol. Chem. 275:8806.
  15. Wang, X. et al. (2002) Mol. Cell 9:411.
  16. Trusolino, L. et al. (2001) Cell 107:643.
  17. Giordano, S. et al. (2002) Nat. Cell Biol. 4:720.
  18. Conrotto, P. et al. (2004) Oncogene 23:5131.
  19. Follenzi, A. et al. (2000) Oncogene 19:3041.
  20. Sonnenberg, E. et al. (1993) J. Cell Biol. 123:223.
Long Name
Hepatocyte Growth Factor Receptor
Entrez Gene IDs
4233 (Human); 17295 (Mouse)
Alternate Names
AUTS9; cMET; c-MET; EC 2.7.10; EC 2.7.10.1; hepatocyte growth factor receptor; HGF R; HGF receptor; HGF/SF receptor; HGFR; Met (c-Met); met proto-oncogene (hepatocyte growth factor receptor); met proto-oncogene tyrosine kinase; MET; oncogene MET; Proto-oncogene c-Met; RCCP2; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Citations for Human HGFR/c-MET Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

53 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. A NUMB–EFA6B–ARF6 recycling route controls apically restricted cell protrusions and mesenchymal motility
    Authors: Martina Zobel, Andrea Disanza, Francesca Senic-Matuglia, Michel Franco, Ivan Nicola Colaluca, Stefano Confalonieri et al.
    Journal of Cell Biology
  2. MET-dependent solid tumours — molecular diagnosis and targeted therapy
    Authors: Robin Guo, Jia Luo, Jason Chang, Natasha Rekhtman, Maria Arcila, Alexander Drilon
    Nature Reviews Clinical Oncology
  3. c-met is overexpressed in type I ovarian cancer: Results of an investigative analysis in a cohort of consecutive ovarian cancer patients
    Authors: Marco Johannes Battista, Marcus Schmidt, Sina Jakobi, Cristina Cotarelo, Katrin Almstedt, Anne-Sophie Heimes et al.
    Oncology Letters
  4. Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists
    Authors: Douglas S. Jones, Ping-Chuan Tsai, Jennifer R. Cochran
    Proceedings of the National Academy of Sciences
  5. Candida albicans stimulates formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection
    Authors: Quynh T. Phan, Norma V. Solis, Max V. Cravener, Marc Swidergall, Jianfeng Lin, Manning Y. Huang et al.
    PLOS Pathogens
  6. Hepatocyte Growth Factor and MET Support Mouse Enteric Nervous System Development, the Peristaltic Response, and Intestinal Epithelial Proliferation in Response to Injury
    Authors: Marina Avetisyan, Hongtao Wang, Ellen Merrick Schill, Saya Bery, John R. Grider, John A. Hassell et al.
    The Journal of Neuroscience
  7. RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells
    Authors: Ahmad F. Alghanem, Emma L. Wilkinson, Maxine S. Emmett, Mohammad A. Aljasir, Katherine Holmes, Beverley A. Rothermel et al.
    Angiogenesis
  8. Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays
    Authors: Apurva K. Srivastava, Melinda G. Hollingshead, Jennifer Weiner, Tony Navas, Yvonne A. Evrard, Sonny A. Khin et al.
    Clinical Cancer Research
  9. Anti-c-Met antibodies recognising a temperature sensitive epitope, inhibit cell growth
    Authors: Julin S. Wong, Emma Warbrick, Borek Vojtesek, Jeffrey Hill, David P. Lane
    Oncotarget
  10. A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors
    Authors: David S. Hong, Peter Rosen, A. Craig Lockhart, Siqing Fu, Filip Janku, Razelle Kurzrock et al.
    Oncotarget
  11. Necrosis- and apoptosis-related Met cleavages have divergent functional consequences
    Authors: R Montagne, M Berbon, L Doublet, N Debreuck, A Baranzelli, H Drobecq et al.
    Cell Death & Disease
  12. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma
    Authors: Javier Puente, Nuria Laínez, Marta Dueñas, María José Méndez-Vidal, Emilio Esteban, Daniel Castellano et al.
    Oncotarget
  13. Single-Molecule Super-Resolution Microscopy Reveals Heteromeric Complexes of MET and EGFR upon Ligand Activation
    Authors: MIE Harwardt, MS Schröder, Y Li, S Malkusch, P Freund, S Gupta, N Janjic, S Strauss, R Jungmann, MS Dietz, M Heilemann
    Int J Mol Sci, 2020-04-17;21(8):.
  14. CLIP‐170 spatially modulates receptor tyrosine kinase recycling to coordinate cell migration
    Authors: Kossay Zaoui, Stephanie Duhamel, Christine A. Parachoniak, Morag Park
    Traffic
  15. Novel Role for Endogenous Hepatocyte Growth Factor in the Pathogenesis of Intracranial Aneurysms
    Authors: Ricardo A. Peña-Silva, Nohra Chalouhi, Lauren Wegman-Points, Muhammad Ali, Ian Mitchell, Gary L. Pierce et al.
    Hypertension
  16. Rhodocetin-alpha beta –induced Neuropilin-1–cMet Association Triggers Restructuring of Matrix Contacts in Endothelial Cells
    Authors: Stephan Niland, Bartosz Ditkowski, Désirée Parrandier, Lise Roth, Hellmut Augustin, Johannes A. Eble
    Arteriosclerosis, Thrombosis, and Vascular Biology
  17. Knockout of c-Cbl/Cbl-b slows c-Met trafficking resulting in enhanced signaling in corneal epithelial cells
    Authors: Tarvestad-Laise, K;Ceresa, BP;
    The Journal of biological chemistry
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  18. MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-gamma )-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells
    Authors: Song, KY;Han, YH;Roehrich, H;Brown, ME;Torres-Cabala, C;Giubellino, A;
    Cancers
    Species: Human
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation, Western Blot
  19. Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination
    Authors: Modica, C;Cortese, M;Bersani, F;Lombardi, AM;Napoli, F;Righi, L;Taulli, R;Basilico, C;Vigna, E;
    Cancers
    Species: Human
    Sample Types: Cell Lysates
    Applications: ELISA Capture
  20. Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
    Authors: K Koo, A Wuenschman, A Rendahl, KY Song, C Forster, A Wolf-Ringw, A Borgatti, A Giubellino
    Veterinary sciences, 2023-03-26;10(4):.
    Species: Canine
    Sample Types: Cell Lysates
    Applications: Western Blot
  21. Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis.
    Authors: Zuo Q, Yang Y, Lyu Y, Yang C, Chen C, Salman S, Huang T, Wicks E, Jackson W, Datan E, Qin W, Semenza G
    Cell Rep, 2023-02-28;42(3):112164.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  22. The Impact of Nanobody Density on the Targeting Efficiency of PEGylated Liposomes
    Authors: BS Mesquita, MHAM Fens, A Di Maggio, EDC Bosman, WE Hennink, M Heger, S Oliveira
    International Journal of Molecular Sciences, 2022-11-29;23(23):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  23. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets
    Authors: Q Zhang, DK Jeppesen, JN Higginboth, R Graves-Dea, VQ Trinh, MA Ramirez, Y Sohn, AC Neininger, N Taneja, ET McKinley, H Niitsu, Z Cao, R Evans, SE Glass, KC Ray, WH Fissell, S Hill, KL Rose, WJ Huh, MK Washington, GD Ayers, DT Burnette, S Sharma, LH Rome, JL Franklin, YA Lee, Q Liu, RJ Coffey
    Nature Cell Biology, 2021-12-09;23(12):1240-1254.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  24. The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells
    Authors: P Banerjee, GY Xiao, X Tan, VJ Zheng, L Shi, MNB Rabassedas, HF Guo, X Liu, J Yu, L Diao, J Wang, WK Russell, J Roszik, CJ Creighton, JM Kurie
    Nature Communications, 2021-11-03;12(1):6354.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  25. RAL GTPases mediate EGFR-driven intestinal stem cell proliferation and tumourigenesis
    Authors: M Nászai, K Bellec, Y Yu, A Román-Fern, E Sandilands, J Johansson, AD Campbell, JC Norman, OJ Sansom, DM Bryant, JB Cordero
    Elife, 2021-06-07;10(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: ELISA Capture
  26. The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry
    Authors: C Fedeli, H Moreno, S Kunz
    Viruses, 2020-08-06;12(8):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  27. FCHSD2 controls oncogenic ERK1/2 signaling outcome by regulating endocytic trafficking
    Authors: GY Xiao, SL Schmid
    PLoS Biol., 2020-07-17;18(7):e3000778.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  28. Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer
    Authors: R Graves-Dea, G Bogatcheva, S Rehman, Y Lu, JN Higginboth, B Singh
    Oncotarget, 2019-02-12;10(13):1320-1333.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  29. Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels
    Authors: D Novo, N Heath, L Mitchell, G Caligiuri, A MacFarlane, D Reijmer, L Charlton, J Knight, M Calka, E McGhee, E Dornier, D Sumpton, S Mason, A Echard, K Klinkert, J Secklehner, F Kruiswijk, K Vousden, IR Macpherson, K Blyth, P Bailey, H Yin, LM Carlin, J Morton, S Zanivan, JC Norman
    Nat Commun, 2018-11-29;9(1):5069.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  30. The association of semaphorin 5A with lymph node metastasis and adverse prognosis in cervical cancer
    Authors: JB Xiao, XL Li, L Liu, G Wang, SN Hao, HJ Dong, XM Wang, YF Zhang, HD Liu
    Cancer Cell Int., 2018-06-22;18(0):87.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  31. Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes
    Authors: ML Scott, DT Coleman, KC Kelly, JL Carroll, B Woodby, WK Songock, JA Cardelli, JM Bodily
    Virology, 2018-03-31;519(0):1-11.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  32. Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes
    Authors: Rachel Barrow-McG
    Nat Commun, 2016-06-23;7(0):11942.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  33. Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer
    Authors: Deborah R Kaye
    PLoS ONE, 2016-06-14;11(6):e0157130.
    Species: Human
    Sample Types: Plasma
    Applications: ELISA Development (Detection)
  34. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.
    Authors: Zoratti G, Tanabe L, Varela F, Murray A, Bergum C, Colombo E, Lang J, Molinolo A, Leduc R, Marsault E, Boerner J, List K
    Nat Commun, 2015-04-15;6(0):6776.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  35. A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases.
    Authors: Tabernero J, Elez M, Herranz M, Rico I, Prudkin L, Andreu J, Mateos J, Carreras M, Han M, Gifford J, Credi M, Yin W, Agarwal S, Komarnitsky P, Baselga J
    Clin Cancer Res, 2014-03-14;20(10):2793-804.
    Species: Human
    Sample Types: Serum
    Applications: ELISA Development (Detection)
  36. Internalization of Met requires the co-receptor CD44v6 and its link to ERM proteins.
    Authors: Hasenauer S, Malinger D, Koschut D, Pace G, Matzke A, von Au A, Orian-Rousseau V
    PLoS ONE, 2013-04-23;8(4):e62357.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  37. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion.
    Authors: Muller, P A J, Trinidad, A G, Timpson, P, Morton, J P, Zanivan, S, van den Berghe, P V E, Nixon, C, Karim, S A, Caswell, P T, Noll, J E, Coffill, C R, Lane, D P, Sansom, O J, Neilsen, P M, Norman, J C, Vousden, K H
    Oncogene, 2012-05-14;32(10):1252-65.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  38. Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide.
    Authors: Cho K, Park J, Park C, Lee D, Lee E, Kim D, Kim K, Yoon S, Park Y, Kim E, Cho S, Jang S, Park B, Chi S, Yoo S, Jang M, Kim H, Kim E, Jo K, Park Y
    Oncogene, 2012-04-23;32(8):1018-29.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  39. c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase.
    Authors: Szabo R, Rasmussen AL, Moyer AB
    Oncogene, 2011-01-10;30(17):2003-16.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  40. Dorsal ruffle microdomains potentiate Met receptor tyrosine kinase signaling and down-regulation.
    Authors: Abella JV, Parachoniak CA, Sangwan V, Park M
    J. Biol. Chem., 2010-06-07;285(32):24956-67.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  41. Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells.
    Authors: Xu L, Nilsson MB, Saintigny P, Cascone T, Herynk MH, Du Z, Nikolinakos PG, Yang Y, Prudkin L, Liu D, Lee JJ, Johnson FM, Wong KK, Girard L, Gazdar AF, Minna JD, Kurie JM, Wistuba II, Heymach JV
    Oncogene, 2010-02-15;29(18):2616-27.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  42. Effect of human patient plasma ex vivo treatment on gene expression and progenitor cell activation of primary human liver cells in multi-compartment 3D perfusion bioreactors for extra-corporeal liver support.
    Authors: Schmelzer E, Mutig K, Schrade P, Bachmann S, Gerlach JC, Zeilinger K
    Biotechnol. Bioeng., 2009-07-01;103(4):817-27.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  43. Decorin is a novel antagonistic ligand of the Met receptor.
    Authors: Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV
    J. Cell Biol., 2009-05-11;185(4):743-54.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  44. Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis.
    Authors: Bogatkevich GS, Ludwicka-Bradley A, Highland KB, Hant F, Nietert PJ, Singleton CB, Feghali-Bostwick CA, Silver RM
    Arthritis Rheum., 2007-07-01;56(7):2432-42.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  45. Bronchial epithelial cell growth regulation in fibroblast cocultures: the role of hepatocyte growth factor.
    Authors: Skibinski G, Elborn JS, Ennis M
    Am. J. Physiol. Lung Cell Mol. Physiol., 2007-03-23;293(1):L69-76.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  46. Candida albicans stimulates the formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection
    Authors: QT Phan, NV Solis, MV Cravener, M Swidergall, J Lin, MY Huang, H Liu, S Singh, AS Ibrahim, M Mazzone, AP Mitchell, SG Filler
    bioRxiv : the preprint server for biology, 2023-02-23;0(0):.
  47. Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering
    Authors: W Li, A Dick, F Lu, H Zhang, H Sun
    Sci Rep, 2019-02-13;9(1):1988.
  48. Cytochalasin B Treatment and Osmotic Pressure Enhance the Production of Extracellular Vesicles (EVs) with Improved Drug Loading Capacity
    Authors: Ashita Nair, Jiyoon Bu, Piper A. Rawding, Steven C. Do, Hangpeng Li, Seungpyo Hong
    Nanomaterials (Basel)
  49. Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
    Authors: Brian K McNeil, Maximiliano Sorbellini, Robert L Grubb, Andrea B Apolo, Fabiola Cecchi, Gagani Athauda et al.
    Journal of Translational Medicine
  50. Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells
    Authors: Marina S Dietz, Daniel Ha beta e, Davide M Ferraris, Antonia Göhler, Hartmut H Niemann, Mike Heilemann
    BMC Biophysics
  51. Arf6 regulates RhoB subcellular localization to control cancer cell invasion
    Authors: Kossay Zaoui, Charles V. Rajadurai, Stéphanie Duhamel, Morag Park
    Journal of Cell Biology
  52. Single nuclei RNA-seq of mouse placental labyrinth development
    Authors: Bryan Marsh, Robert Blelloch
    eLife
  53. Receptor-based mechanism of relative sensing and cell memory in mammalian signaling networks
    Authors: Eugenia Lyashenko, Mario Niepel, Purushottam D Dixit, Sang Kyun Lim, Peter K Sorger, Dennis Vitkup
    eLife

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human HGFR/c-MET Antibody

There are currently no reviews for this product. Be the first to review Human HGFR/c-MET Antibody and earn rewards!

Have you used Human HGFR/c-MET Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review